GlassScriptPhysician profile
April D Brock
NPI 1609399286
$1,019.99
in general payments reported to CMS, 2019-2025
23 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $523 · 2023: $182 · 2024: $197 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $110.47 | 2022-2024 | |
| Davol INC. | $95.36 | 2022 | |
| Sumitomo Pharma America, INC. | $94.96 | 2023-2024 | Gemtesa |
| Urogen Pharma, INC. | $76.30 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $65.16 | 2022 | |
| 180 Medical, INC. | $62.71 | 2022-2024 | |
| Olympus America INC. | $58.91 | 2023-2025 | Itind System |
| Merck Sharp & Dohme LLC | $55.76 | 2022-2023 | Keytruda |
| Boston Scientific Corporation | $51.13 | 2022 | |
| Braintree Laboratories, INC. | $46.14 | 2022-2025 | Suflave |
| Pacira Pharmaceuticals Incorporated | $41.97 | 2022-2023 | Exparel |
| Vertex Pharmaceuticals Incorporated | $36.59 | 2025 | |
| Accord Healthcare, INC. | $33.87 | 2022-2024 | |
| Janssen Biotech, INC. | $29.60 | 2022-2023 | Erleada |
| Aimmune Therapeutics, INC. | $28.07 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $26.60 | 2022 | |
| Organogenesis INC. | $20.30 | 2024 | |
| Astellas Pharma US INC | $14.99 | 2023 | Myrbetriq |
| Ambu INC. | $14.81 | 2022 | |
| Medtronic, INC. | $14.76 | 2023 | Bravo |
| Polynovo North America LLC | $14.08 | 2024 | Novosorb Btm |
| Takeda Pharmaceuticals U.S.A., INC. | $14.00 | 2023 | Gattex |
| Axonics, INC. | $13.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Brock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.